Coronavirus disease 2019 (COVID-19) is a threat to patients not only because of its acute course, but also because of various complications occurring in the following period, that is, more than 28 days after the onset of acute infection. The present study identified a total of 121 patients hospitalized 29 or more days after the first positive result of a PCR test for SARS-CoV-2, of whom 98 patients were included in the study. Patients were divided into two groups by the time interval between the positive COVID-19 test result and hospitalization date. The time intervals were week 5-11 in an ongoing-COVID group (57.1% of patients) and 12 or more weeks in a post-COVID-group (42.9%). The most frequent reason for hospitalization was respiratory tract infection (58.2%). Pneumonia accounted for 77.2% of these cases. Other reasons for hospitalization were interstitial lung disease (22.4%), pulmonary embolism (8.2%), and sarcoidosis (6.1%). The study group was further divided according to the causes of hospitalization into subgroups with infections and other causes. In the group with infectious diseases, there was a shorter time period between PCR positivity and hospitalization and there were significantly more frequent non-respiratory complications. In the entire sample, the in-hospital mortality was 5.1%.

Department of Microbiology Faculty of Medicine and Dentistry Palacký University Olomouc Hněvotínská 3 77900 Olomouc Czech Republic

Department of Pulmonary Diseases and Tuberculosis Faculty of Medicine and Dentistry Palacký University Olomouc Hněvotínská 3 77900 Olomouc Czech Republic

Department of Pulmonary Diseases and Tuberculosis University Hospital Olomouc 1 P Pavlova 185 6 77900 Olomouc Czech Republic

See more in PubMed

Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136. PubMed DOI

Oronsky B., Larson C., Hammond T.C., Oronsky A., Kesari S., Lybeck M., Reid T.R. A Review of Persistent Post-COVID Syndrome (PPCS) Clin. Rev. Allergy Immunol. 2021;20:114. doi: 10.1007/s12016-021-08848-3. PubMed DOI PMC

Hamers L., Kox M., Pickkers P. Sepsis-induced immunoparalysis: Mechanisms, markers, and treatment options. Minerva Anestesiol. 2015;81:426–439. PubMed

Xu K., Cai H., Shen Y., Ni Q., Chen Y., Hu S., Li J., Wang H., Yu L., Huang H., et al. Management of corona virus disease-19 (COVID-19): The Zhejiang experience. Zhejiang Da Xue Xue Bao Yi Xue Ban J. Zhejiang Univ. Med. Sci. 2020;49:147–157. PubMed PMC

Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J., Fan Y., Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. Lancet Infect. Dis. 2020;20:425–434. doi: 10.1016/S1473-3099(20)30086-4. PubMed DOI PMC

Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737–754. doi: 10.1080/23744235.2021.1924397. PubMed DOI PMC

Hosey M.M., Needham D.M. Survivorship after COVID-19 ICU stay. Nat. Rev. Dis. Primers. 2020;6:60. doi: 10.1038/s41572-020-0201-1. PubMed DOI PMC

Becker R.C. COVID-19 and its sequelae: A platform for optimal patient care, discovery and training. J. Thromb. Thrombolysis. 2021;51:587–594. doi: 10.1007/s11239-021-02375-w. PubMed DOI PMC

Havervall S., Rosell A., Phillipson M., Mangsbo S.M., Nilsson P., Hober S., Thålin C. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. JAMA. 2021;325:2015–2016. doi: 10.1001/jama.2021.5612. PubMed DOI PMC

COVID 19 Long Term Health Effects. [(accessed on 7 May 2021)]; Available online: https://www.gov.uk/government/publications/covid-19-long-term-health-effects/covid-19-long-term-health-effects.

Tenforde M.W., Kim S.S., Lindsell C.J., Billig Rose E., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network—United States, March–June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:993–998. doi: 10.15585/mmwr.mm6930e1. PubMed DOI PMC

Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruyère F., Stefic K., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021;27:258–263. doi: 10.1016/j.cmi.2020.09.052. PubMed DOI PMC

Greenhalgh T., Knight M., A’Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026. PubMed DOI

Office for National Statistics (ONS) The Prevalence of Long COVID Symptoms and COVID-19 Complications. [(accessed on 6 December 2021)]; Available online: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications.

Sonnweber T., Sahanic S., Pizzini A., Luger A., Schwabl C., Sonnweber B., Kurz K., Koppelstätter S., Haschka D., Petzer V., et al. Cardiopulmonary recovery after COVID-19: An observational prospective multicentre trial. Eur. Respir. J. 2021;57:2003481. doi: 10.1183/13993003.03481-2020. PubMed DOI PMC

Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., Noel A., Gunning S., Hatrick J., Hamilton S., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2020;76:399–401. doi: 10.1136/thoraxjnl-2020-216086. PubMed DOI PMC

Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27:89–95. doi: 10.1016/j.cmi.2020.09.023. PubMed DOI PMC

Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., Steig B.Á., Gaini S., Strøm M., Weihe P. Long COVID in the Faroe Islands-a longitudinal study among non-hospitalized patients. Clin. Infect. Dis. 2020;73:e4058–e4063. doi: 10.1093/cid/ciaa1792. PubMed DOI PMC

Goërtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020;6:e00542-2020. doi: 10.1183/23120541.00542-2020. PubMed DOI PMC

Chopra V., Flanders S.A., O’Malley M. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2020;174:576–587. doi: 10.7326/M20-5661. PubMed DOI PMC

Centers for Disease Control and Prevention Late Sequelae of COVID-19. [(accessed on 5 January 2021)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/late-sequelae.html.

Cirulli E.T., Schiabor Barrett K.M., Riffle S., Bolze A., Neveux I., Dabe S., Grzymski J.J., Lu J.T., Washington N.L. Long-term COVID-19 symptoms in a large unselected population. medRxiv. 2020 doi: 10.1101/2020.10.07.20208702. DOI

Carfì A., Bernabei R., Landi F., Gemelli Against COVID-19 PostAcute Care Study Group Persistent Symptoms in Patients after Acute COVID-19. JAMA. 2020;324:603–605. doi: 10.1001/jama.2020.12603. PubMed DOI PMC

European Committee on Antimicrobial Susceptibility Testing Breakpoint Tables for Interpretation of MICs and Zone Diameters. [(accessed on 6 December 2021)]. Available online: http://www.eucast.org/clinical_breakpoints.

Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. TLC Study Group. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428–442. doi: 10.1177/01410768211032850. PubMed DOI PMC

Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220–232. doi: 10.1016/S0140-6736(20)32656-8. PubMed DOI PMC

Bellan M., Soddu D., Balbo P.E., Baricich A., Zeppegno P., Avanzi G.C., Baldon G., Bartolomei G., Battaglia M., Battistini S., et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw. Open. 2021;4:e2036142. doi: 10.1001/jamanetworkopen.2020.36142. PubMed DOI PMC

Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416–427. doi: 10.1016/S2215-0366(21)00084-5. PubMed DOI PMC

Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., Walshaw C., Kemp S., Corrado J., Singh R., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013–1022. doi: 10.1002/jmv.26368. PubMed DOI

Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re’em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019. PubMed DOI PMC

Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H.C., et al. ‘Long-COVID’: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396–398. doi: 10.1136/thoraxjnl-2020-215818. PubMed DOI PMC

D’Cruz R.F., Waller M.D., Perrin F., Periselneris J., Norton S., Smith L.J., Patrick T., Walder D., Heitmann A., Lee K., et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021;7:e00655-2020. doi: 10.1183/23120541.00655-2020. PubMed DOI PMC

Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F., Gong W., Liu X., Liang J., Zhao Q., et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802–810. doi: 10.1001/jamacardio.2020.0950. PubMed DOI PMC

Gasecka A., Pruc M., Kukula K., Gilis-Malinowska N., Filipiak K.J., Jaguszewski M.J., Szarpak L. Post-COVID-19 heart syndrome. Cardiol. J. 2021;28:353–354. doi: 10.5603/CJ.a2021.0028. PubMed DOI PMC

Lu Y., Li X., Geng D., Mei N., Wu P.Y., Huang C.C., Jia T., Zhao Y., Wang D., Xiao A., et al. Cerebral micro-structural changes in COVID-19 patients—An MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484. doi: 10.1016/j.eclinm.2020.100484. PubMed DOI PMC

Stevens J.S., King K.L., Robbins-Juarez S.Y., Khairallah P., Toma K., Alvarado Verduzco H., Daniel E., Douglas D., Moses A.A., Peleg Y., et al. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy. PLoS ONE. 2020;15:e0244131. doi: 10.1371/journal.pone.0244131. PubMed DOI PMC

Velez J.C.Q., Caza T., Larsen C.P. COVAN is the new HIVAN: The re-emergence of collapsing glomerulopathy with COVID-19. Nat. Rev. Nephrol. 2020;16:565–567. doi: 10.1038/s41581-020-0332-3. PubMed DOI PMC

Zuo T., Zhang F., Lui G., Yeoh Y.K., Li A., Zhan H., Wan Y., Chung A., Cheung C.P., Chen N., et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020;159:944–955.e8. doi: 10.1053/j.gastro.2020.05.048. PubMed DOI PMC

Donati Zeppa S., Agostini D., Piccoli G., Stocchi V., Sestili P. Gut Microbiota Status in COVID-19: An Unrecognized Player? Front. Cell. Infect. Microbiol. 2020;10:576551. doi: 10.3389/fcimb.2020.576551. PubMed DOI PMC

Bogdanová K., Doubravská L., Vágnerová I., Hricová K., Pudová V., Röderová M., Papajk J., Uvízl R., Langová K., Kolář M. Clostridioides difficile and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia. Life. 2021;11:1127. doi: 10.3390/life11111127. PubMed DOI PMC

Suwanwongse K., Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID-19: Causality or coincidence? A report of three cases. J. Med. Virol. 2020;93:1150–1153. doi: 10.1002/jmv.26339. PubMed DOI PMC

Tee L.Y., Harjanto S., Rosario B.H. COVID-19 complicated by Hashimoto’s thyroiditis. Singap. Med. J. 2021;62:265. doi: 10.11622/smedj.2020106. PubMed DOI PMC

Mateu-Salat M., Urgell E., Chico A. SARS-CoV-2 as a trigger for autoimmune disease: Report of two cases of Graves’ disease after COVID-19. J. Endocrinol. Investig. 2020;43:1527–1528. doi: 10.1007/s40618-020-01366-7. PubMed DOI PMC

Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-COVID syndrome in individuals admitted to hospital with COVID-19: Retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693. PubMed DOI PMC

Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of Long-COVID. Nat. Med. 2021;27:626–631. doi: 10.1038/s41591-021-01292-y. PubMed DOI PMC

Jacobs L.G., Gourna Paleoudis E., Lesky-Di Bari D., Nyirenda T., Friedman T., Gupta A., Rasouli L., Zetkulic M., Balani B., Ogedegbe C., et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. 2020;15:e0243882. doi: 10.1371/journal.pone.0243882. PubMed DOI PMC

Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: A population-based cohort study. Thorax. 2020;76:405–407. doi: 10.1136/thoraxjnl-2020-216377. PubMed DOI PMC

Galal I., Hussein A., Amin M.T., Saad M.M., Zayan H., Abdelsayed M.Z., Moustafa M.M., Ezzat A.R., Helmy R., Abd_Elaal H.K., et al. Determinants of persistent post-COVID-19 symptoms: Value of a novel COVID-19 symptom score. Egypt. J. Bronchol. 2021;15:10. doi: 10.1186/s43168-020-00049-4. DOI

Wang Y., Dong C., Hu Y., Li C., Ren Q., Zhang X., Shi H., Zhou M. Temporal changes of CT findings in patients with COVID-19 pneumonia: A longitudinal study. Radiology. 2020;296:E55–E64. doi: 10.1148/radiol.2020200843. PubMed DOI PMC

Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q., Ni F., Fang S., Lu Y., Ding X., et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir. Med. 2021;9:747–754. doi: 10.1016/S2213-2600(21)00174-0. PubMed DOI PMC

Torres-Castro R., Vasconcello-Castillo L., Alsina-Restoy X., Solis-Navarro L., Burgos F., Puppo H., Vilaró J. Respiratory function in patients post-infection by COVID-19: A systematic review and meta-analysis. Pulmonology. 2021;27:328–337. doi: 10.1016/j.pulmoe.2020.10.013. PubMed DOI PMC

Lerum T.V., Aaløkken T.M., Brønstad E., Aarli B., Ikdahl E., Lund K., Durheim M.T., Rodriguez J.R., Meltzer C., Tonby K., et al. Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19. Eur. Respir. J. 2020;57:2003448. doi: 10.1183/13993003.03448-2020. PubMed DOI PMC

Zhao Y.M., Shang Y.M., Song W.B., Li Q.Q., Xie H., Xu Q.F., Jia J.L., Li L.M., Mao H.L., Zhou X.M., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463. PubMed DOI PMC

Van den Borst B., Peters J.B., Brink M., Schoon Y., Bleeker-Rovers C.P., Schers H., van Hees H., van Helvoort H., van den Boogaard M., van der Hoeven H., et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin. Infect. Dis. 2021;73:e1089. doi: 10.1093/cid/ciaa1750. PubMed DOI PMC

Moreno-Pérez O., Merino E., Leon-Ramirez J.M., Andres M., Ramos J.M., Arenas-Jiménez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J. Infect. 2021;82:378–383. doi: 10.1016/j.jinf.2021.01.004. PubMed DOI PMC

Tabatabaei S.M.H., Rajebi H., Moghaddas F., Ghasemiadl M., Talari H. Chest CT in COVID-19 pneumonia: What are the findings in mid-term follow-up? Emerg. Radiol. 2020;27:711–719. doi: 10.1007/s10140-020-01869-z. PubMed DOI PMC

Shah A.S., Wong A.W., Hague C.J., Murphy D.T., Johnston J.C., Ryerson C.J., Carlsten C. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2020;76:402–404. doi: 10.1136/thoraxjnl-2020-216308. PubMed DOI

Korompoki E., Gavriatopoulou M., Hicklen R.S., Ntanasis-Stathopoulos I., Kastritis E., Fotiou D., Stamatelopoulos K., Terpos E., Kotanidou A., Hagberg C.A. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J. Infect. 2021;83:1–16. doi: 10.1016/j.jinf.2021.05.004. PubMed DOI PMC

Zoumot Z., Bonilla M.F., Wahla A.S., Shafiq I. Pulmonary cavitation: An under-recognized late complication of severe COVID-19 lung disease. BMC Pulm. Med. 2021;21:24. doi: 10.1186/s12890-020-01379-1. PubMed DOI PMC

Ramzi Z.S. Hospital readmissions and post-discharge all-cause mortality in COVID-19 recovered patients: A systematic review and meta-analysis. Am. J. Emerg. Med. 2021;51:267–279. doi: 10.1016/j.ajem.2021.10.059. PubMed DOI PMC

Atalla E., Kalligeros M., Giampaolo G., Mylona E.K., Shehadeh F., Mylonakis E. Readmissions among patients with COVID-19. Int. J. Clin. Pract. 2021;75:e13700. doi: 10.1111/ijcp.13700. PubMed DOI

Lavery A.M., Preston L.E., Ko J.Y., Chevinsky J.R., DeSisto C.L., Pennington A.F., Kompaniyets L., Datta S.D., Click E.S., Golden T., et al. Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission—United States, March–August 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1695–1699. doi: 10.15585/mmwr.mm6945e2. PubMed DOI PMC

Parra L.M., Cantero M., Morrás I., Vallejo A., Diego I., Jiménez-Tejero E., Múñez E., Asensio Á., Fermández-Cruz A., Ramos-Martinez A., et al. Hospital Readmissions of Discharged Patients with COVID-19. Int. J. Gen. Med. 2020;13:1359–1366. doi: 10.2147/IJGM.S275775. PubMed DOI PMC

Ramos-Martínez A., Parra-Ramírez L.M., Morrás I., Carnevali M., Jiménez-Ibañez L., Rubio-Rivas M., Arnalich F., Beato J.L., Monge D., Asín U., et al. Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients. Sci. Rep. 2021;11:13733. doi: 10.1038/s41598-021-93076-0. PubMed DOI PMC

Kirkegaard C., Falcó-Roget A., Sánchez-Montalvá A., Valls Á., Clofent D., Campos-Varela I., García-García S., Leguízamo L.M., Sellarès-Nadal J., Eremiev S., et al. Incidence and risk factors for early readmission after hospitalization for SARS-CoV-2 infection: Results from a retrospective cohort study. Infection. 2021;2:1. doi: 10.1007/s15010-021-01662-1. PubMed DOI PMC

Yeo I., Baek S., Kim J., Elshakh H., Voronina A., Lou M.S., Vapnik J., Kaler R., Dai X., Goldbarg S. Assessment of thirty-day readmission rate, timing, causes and predictors after hospitalization with COVID-19. J. Intern. Med. 2021;290:157–165. doi: 10.1111/joim.13241. PubMed DOI PMC

Donnelly J., Qing Wang X., Iwashyna T. Readmission and Death After Initial Hospital Discharge Among Patients with COVID-19 in a Large Multihospital System. JAMA. 2021;325:304–306. doi: 10.1001/jama.2020.21465. PubMed DOI PMC

Clark J.R., Batra A., Shlobin N.A., Hoffman S.C., Orban Z.S., Koralnik I.J., Liotta E.M. Acute-care hospital reencounters in COVID-19 patients. GeroScience. 2021;43:2041–2053. doi: 10.1007/s11357-021-00378-2. PubMed DOI PMC

Günster C., Busse R., Spoden M., Rombey T., Schillinger G., Hoffmann W., Weber-Carstens S., Schuppert A., Karagiannidis C. 6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8679 patients in Germany. PLoS ONE. 2021;16:e0255427. doi: 10.1371/journal.pone.0255427. PubMed DOI PMC

Romero-Duarte Á., Rivera-Izquierdo M., Guerrero-Fernández de Alba I., Pérez-Contreras M., Fernández-Martínez N.F., Ruiz-Montero R., Serrano-Ortiz Á., González-Serna R.O., Salcedo-Leal I., Jiménez-Mejías E., et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: The ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021;19:129. doi: 10.1186/s12916-021-02003-7. PubMed DOI PMC

Guarin G., Lo K.B., Bhargav R., Salacup G., Wattoo A., Coignet J.G., DeJoy R., Azmaiparashvili Z., Patarroyo-Aponte G., Eiger G., et al. Factors associated with hospital readmissions among patients with COVID-19: A single-center experience. J. Med. Virol. 2021;93:5582–5587. doi: 10.1002/jmv.27104. PubMed DOI PMC

Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. PubMed DOI PMC

Ambardar S.R., Hightower S.L., Huprikar N.A., Chung K.K., Singhal A., Collen J.F. Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic. J. Clin. Med. 2021;10:2452. doi: 10.3390/jcm10112452. PubMed DOI PMC

Huang W., Wu Q., Chen Z., Xiong Z., Wang K., Tian J., Zhang S. The potential indicators for pulmonary fibrosis in survivors of severe COVID-19. J. Infect. 2021;82:e5–e7. doi: 10.1016/j.jinf.2020.09.027. PubMed DOI PMC

Yu M., Liu Y., Xu D., Zhang R., Lan L., Xu H. Prediction of the development of pulmonary fibrosis using serial thin-section CT and clinical features in patients discharged after treatment for COVID-19 pneumonia. Korean J. Radiol. 2020;21:746–755. doi: 10.3348/kjr.2020.0215. PubMed DOI PMC

Hu Z.J., Xu J., Yin J.M., Li L., Hou W., Zhang L.L., Zhou Z., Yu Y.Z., Li H.J., Feng Y.M., et al. Lower circulating interferon-gamma is a risk factor for lung fibrosis in COVID-19 patients. Front. Immunol. 2020;11:585647. doi: 10.3389/fimmu.2020.585647. PubMed DOI PMC

Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. PubMed DOI PMC

Halpin D.M.G., Singh D., Hadfield R.M. Inhaled corticosteroids and COVID-19: A systematic review and clinical perspective. Eur. Respir. J. 2020;55:2001009. doi: 10.1183/13993003.01009-2020. PubMed DOI PMC

Sokolowska M., Lukasik Z.M., Agache I., Akdis C.A., Akdis D., Akdis M., Barcik W., Brough H.A., Eiwegger T., Eljaszewicz A., et al. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI) Allergy. 2020;75:2445–2476. doi: 10.1111/all.14462. PubMed DOI PMC

Zeng Q.L., Li G.M., Ji F., Ma S.H., Zhang G.F., Xu J.H., Lin W.B., Xu G.H., Zhang G.Q., Li G.T., et al. Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: A multicentre, retrospective study. Transbound. Emerg. Dis. 2020;67:2971–2982. doi: 10.1111/tbed.13674. PubMed DOI PMC

Ye Z., Zhang Y., Wang Y., Huang Z., Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): A pictoral review. Eur. Radiol. 2020;30:4381–4389. doi: 10.1007/s00330-020-06801-0. PubMed DOI PMC

Vadukul P., Sharma D., Vincent P. Massive pulmonary embolism following recovery from COVID-19 infection: Inflammation, thrombosis and the role of extended thromboprophylaxis. BMJ Case Rep. 2020;13:e238168. doi: 10.1136/bcr-2020-238168. PubMed DOI PMC

Taha M., Nguyen P., Sharma A., Taha M., Samavati L. Forty-One-Year-Old Man with Pulmonary Embolism 5 Months After COVID-19. Clin. Med. Insights Circ. Respir. Pulm. Med. 2021;15:1179548420986659. doi: 10.1177/1179548420986659. PubMed DOI PMC

Vechi H.T., Maia L.R., Alves M.D.M. Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): A case series. Rev. Inst. Med. Trop. Sao Paulo. 2020;62:e63. doi: 10.1590/s1678-9946202062063. PubMed DOI PMC